Drugs - HealthQuill

Scientists are close to developing a human treatment for nonalcoholic fatty liver after they successfully developed a compound tested in non-human primates.

Cure for nonalcoholic fatty liver disease may be near: Scientists say

HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.

by HealthQuill
April 11, 2023
0 Comments

Drugs Health Medical Pharma

Cipla, Novartis team up to make, market anti-diabetic drug

HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.

by HealthQuill
April 10, 2023
0 Comments

Moderna, a US-based biotechnology company, hopeful of cancer vaccine by 2030

Drugs Health Medical Pharma

Cancer and cardio vaccines will be available by end 2030, says Moderna executive

HQ Team April 8, 2023: Cancer vaccines will be ready by the end of this decade, according to pharmaceutical company Moderna’s chief medical.

by HealthQuill
April 8, 2023
0 Comments

The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove its benefits in clinical trials.

Drugs Health Medical Pharma

FDA withdraws approval for Covis’ preterm birth prevention drug

HQ Team April 7, 2023: The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove.

by HealthQuill
April 7, 2023
0 Comments

Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.

Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

by HealthQuill
April 7, 2023
0 Comments

Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use of its patents in making COVID-19 vaccines.

Drugs Health Medical Pharma

Arbutus drags Pfizer, BioNTech to court over patent infringements

HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.

by HealthQuill
April 5, 2023
0 Comments

U.S. Bankruptcy Court for the District of New Jersey

Drugs Health Medical Pharma

J&J raises talc settlement to $8.9 billion, unit files for a second bankruptcy

HQ Team April 5, 2023: Johnson and Johnson, a US multinational making pharmaceuticals and medical devices, has offered to pay $8.9 billion to.

by HealthQuill
April 5, 2023
0 Comments

BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.

Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

by HealthQuill
April 3, 2023
0 Comments

Drugs Medical Pharma

Global Pharma recalls eye drops in US after ‘possible’ contamination

The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states.